Capabilities by Region: Australia
Greenhill has considerable advisory experience in Australia. Our Managing Directors and professionals have advised clients on transactions involving many of the leading companies in the region and have access to a network of corporate relationships throughout Australia.
Greenhill established its presence in Australia in April 2010 with the acquisition of Caliburn, the leading independent investment bank in the region.
For more information on Greenhill’s advisory practice in Australia and our capabilities in the region, please contact Managing Director Roger Feletto or Richard Phillips.
Below we highlight a few of the recent transactions on which we have advised in this region:
Recent Transactions
Sort By
Western Sydney Airport
Advised the Commonwealth Government of Australia as represented by the Department of Infrastructure and Regional Development in relation to the Western Sydney Airport (Peer Review and other strategic advisory services)
The Franklin Printing Group Pty Ltd (“Franklin Web”) and Taverners No.13 Pty Ltd (“AIW Printing”)
Advised ASX-listed IVE Group, a leading marketing and print communications provider in Australia, on the simultaneous acquisitions of Franklin Web and AIW Printing, specialist catalogue producers, and its equity capital raising via a placement and a rights issue
Lion’s Australian Premium Wine Business – Fine Wine Partners
Advised Lion, a leading Australasian food and beverage company wholly owned by Japanese conglomerate Kirin, on the sale of its Australian wine business Fine Wine Partners to Accolade Wines, a portfolio company of CHAMP Private Equity
Bionomics Limited
Advised ASX-listed Bionomics, a clinical stage biopharmaceutical company focused on the treatment of serious central nervous system disorders and cancer, on a consultation process with shareholders following calls for Board change, leading to the formation of a shareholder working group of leading institutional investors and company-led Board renewal.
US rights to 37 approved and 5 pipeline generic products
Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to 42 generic products